General

The New Mexico Department of Health (NMDOH) is seeing low influenza activity statewide and considers the need for seasonal precautions for the prevention of influenza to be over. Moving forward, only occasional and isolated cases of influenza are likely to occur. However, with sporadic influenza activity, it is still possible to see rare summer-time outbreaks of influenza-like illness (ILI), and COVID-19 activity remains unpredictable. ILI is defined as fever of greater than 100° F and cough and/or sore throat in the absence of another known cause. An influenza outbreak is defined as one confirmed case of influenza (by PCR test) and any other cases of ILI in the same geographic location. Since flu circulation is likely to be low outside of the main respiratory season, any rapid positive influenza results should be confirmed by PCR before declaring an outbreak. Outbreaks should be reported to the on-call epidemiologist 24/7/365 at (505) 827-0006.

Department of Public Safety Announcement Letter April 10, 2023

Department of Public Safety Announcement Letter April 17, 2023

Department of Public Safety Announcement Letter April 21, 2023

Department of Public Safety Announcement Letter April 27, 2023

Caregiver Criminal History Screening Program Letter April 28, 2023

Overview of IDEMIA New Mexico Applicant Solution PowerPoint

New Mexico Application Registration Process

New Mexico Non-Resident/Fingerprint Card Scan Overview PowerPoint

Fingerprint background check services Frequently Asked Questions (FAQs)

Map of Fingerprint Location Sites

List of acceptable IDs needed for enrollment

Guidance on Multi-factor Authentication Applications

IDEMIA Background Check Result Access PowerPoint

Northwest Region Health Promotion Team

The CDC and FDA have streamlined COVID-19 vaccine recommendations, authorizing the use of bivalent COVID-19 vaccines for all recommended doses. In addition, previously unvaccinated individuals ages 6 and older are now recommended to receive one dose of a bivalent COVID-19 vaccine, and people ages 65 and older and those with immune compromise can receive a second bivalent vaccine. The monovalent Moderna and Pfizer-BioNTech COVID-19 vaccines are no longer authorized for use in the United States.

COVID-19

COVID-19 Factsheet (English)
COVID-19 Factsheet (Spanish)

VFC Program Staff Listing

Health Council Priorities FY23 rev 3-17-23

The U.S. Drug Enforcement Agency (DEA) recently issued an alert regarding overdose deaths in the US linked to Xylazine, a non-opioid central nervous system depressant. It is used as a sedative, anesthetic, muscle relaxant, and analgesic in veterinary medicine and has not been approved for use in humans. Xylazine is usually mixed with other illicit drugs, like fentanyl, because it causes the effects of opioids to last longer. In New Mexico, six xylazine-involved deaths were reported in the last five years. Xylazine is an unscheduled drug that is easily accessed, so its presence in the illicit drug supply may increase over time, due to its low cost. Reports indicate that xylazine, alone or in combination with other drugs, is administered by injecting, snorting, swallowing, or inhaling it.